Abstract

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5

Page(s): 409

Download in electronic PDF format for $75

Abstract

A formulation for preparing Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2019 Pg. 409	Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 164-166	Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Author(s): Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2020 Pg. 140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Nov/Dec 2019 Pg. 504-510	Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2017 Pg. 500-512	To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
May/Jun 2023 Pg. 250-255	Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base Author(s): Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
Sep/Oct 2006 Pg. 389	Omeprazole 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 250-253	Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Author(s): Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 420-427	Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Jul/Aug 2013 Pg. 344-346	Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jan/Feb 2010 Pg. 82-85	Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Author(s): Voudrie Mark A II, Allen D Brett
Jul/Aug 2018 Pg. 321	Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 56	Ranitidine 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 417-423	Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Jul/Aug 2013 Pg. 336-338	Stability of Captopril in SyrSPend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jul/Aug 2012 Pg. 347-349	Stability of Gabapentin in SyrSpend SF Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan